Abstract
No public abstract is available from the verified source records.
Jukun Song
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
openalex
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Prevalence and risk factors of hyperuricemia and gout: a cross-sectional survey from 31 provinces in mainland China
10.2478/jtim-2022-0031 · 2022
A comprehensive analysis of trends in the burden of gout in China and globally from 1990 to 2021
10.1038/s41598-025-86090-z · 2025
A systematic review of the cost burden of gout
10.1016/j.jval.2015.09.2371 · 2015
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
10.1186/s12916-017-0890-9 · 2017
Erratum: Department of Error (The Lancet (2021) 397 (10287)(1843–1855),(S0140673621005699),(10.1016/S0140-6736 (21) 00569-9))
2021
The burden of severe periodontitis in China from 1990 to 2021, with projections to 2050: a comprehensive analysis from the global burden of disease study 2021
10.1016/j.identj.2024.12.013 · 2025
Periodontitis: from microbial immune subversion to systemic inflammation
10.1038/nri3785 · 2015
The prevalence and severity of periodontal disease in Mainland China: data from the fourth national oral health survey (2015–2016)
10.1111/jcpe.13396 · 2021
Impact of nonsurgical periodontal treatment on arterial stiffness outcomes related to endothelial dysfunction: A systematic review and meta-analysis
datacite
Confidence 0%
10.1002/jper.24-0422 · 2025
Impact and efficacy of systemic antibiotics for peri-implant diseases treatment: a systematic review and meta-analysis on clinical and microbiological outcomes
2000
Recent progress and perspectives on the relationship between hyperuricemia and periodontitis
10.3389/fimmu.2022.995582 · 2022
Gout can increase the risk of periodontal disease in Taiwan
10.1080/00325481.2020.1757267 · 2020
Association between periodontitis and uric acid levels in blood and oral fluids: a systematic review and meta-analysis
10.1186/s12903-023-02900-8 · 2023
Gout-associated uric acid crystals activate the NALP3 inflammasome
10.1038/nature04516 · 2006
The role of inflammasome NLPR3 in the development and therapy of periodontitis
10.7150/ijms.74575 · 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
2022
Effectiveness of non-surgical periodontal therapy in a large Chinese population with chronic periodontitis
10.1111/jcpe.12637 · 2017
Analyzing the association between hyperuricemia and periodontitis: a cross-sectional study using KoGES HEXA data
10.3390/ijerph17134777 · 2020
Hyperuricemia and elevated uric acid/creatinine ratio are associated with stages III/IV periodontitis: a population-based cross-sectional study (NHANES 2009–2014)
10.1186/s12903-024-05173-x · 2024
Unresolved referenced work
2024
Unresolved referenced work
2022
2024 update of chinese guidelines for diagnosis and treatment of hyperuricemia and gout part I: recommendations for general patients
10.1111/1756-185x.70375 · 2025
Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis
10.1136/bmjopen-2017-017542 · 2018
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Estimating an EQ-5D-5L value set for China
10.1016/j.jval.2016.11.016 · 2017
Periodontitis and oral health-related quality of life: a systematic review and meta-analysis
10.1111/jcpe.14074 · 2025
Use of the gout impact scale to evaluate quality of life in Chinese subjects with gout: a cross-sectional study
10.12659/msm.925593 · 2020
Impact of gout flare on health-related quality of life: a multi-center cross-sectional study in Thailand
10.1007/s10067-025-07339-6 · 2025
Health and utilities in patients with gout under the care of a rheumatologist
10.1002/acr.22551 · 2015
Reliability and validity of a Chinese version of the oral health impact profile for edentulous subjects
10.1007/s11136-014-0822-5 · 2015
Budget impact analysis—principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force
10.1016/j.jval.2013.08.2291 · 2014
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review: Tan Minh Nguyen et al
10.1007/s40258-022-00758-5 · 2023
Impact of treating oral disease on preventing vascular diseases: a model-based cost-effectiveness analysis of periodontal treatment among patients with type 2 diabetes
10.2337/dc19-1201 · 2020
Impact of treating oral disease on preventing vascular diseases: a model-based cost-effectiveness analysis of periodontal treatment among patients with type 2 diabetes
10.2337/dc19-1201 · doi-reference
Economic Evaluations of Preventive Interventions for Dental Caries and Periodontitis: A Systematic Review: Tan Minh Nguyen et al
10.1007/s40258-022-00758-5 · doi-reference
Budget impact analysis—principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force
10.1016/j.jval.2013.08.2291 · doi-reference
Reliability and validity of a Chinese version of the oral health impact profile for edentulous subjects
10.1007/s11136-014-0822-5 · doi-reference
Health and utilities in patients with gout under the care of a rheumatologist
10.1002/acr.22551 · doi-reference
Impact of gout flare on health-related quality of life: a multi-center cross-sectional study in Thailand
10.1007/s10067-025-07339-6 · doi-reference
Use of the gout impact scale to evaluate quality of life in Chinese subjects with gout: a cross-sectional study
10.12659/msm.925593 · doi-reference
Periodontitis and oral health-related quality of life: a systematic review and meta-analysis
10.1111/jcpe.14074 · doi-reference
Estimating an EQ-5D-5L value set for China
10.1016/j.jval.2016.11.016 · doi-reference
Rate of adherence to urate-lowering therapy among patients with gout: a systematic review and meta-analysis
10.1136/bmjopen-2017-017542 · doi-reference
2024 update of chinese guidelines for diagnosis and treatment of hyperuricemia and gout part I: recommendations for general patients
10.1111/1756-185x.70375 · doi-reference
Hyperuricemia and elevated uric acid/creatinine ratio are associated with stages III/IV periodontitis: a population-based cross-sectional study (NHANES 2009–2014)
10.1186/s12903-024-05173-x · doi-reference
Analyzing the association between hyperuricemia and periodontitis: a cross-sectional study using KoGES HEXA data
10.3390/ijerph17134777 · doi-reference
Effectiveness of non-surgical periodontal therapy in a large Chinese population with chronic periodontitis
10.1111/jcpe.12637 · doi-reference
The role of inflammasome NLPR3 in the development and therapy of periodontitis
10.7150/ijms.74575 · doi-reference
Gout-associated uric acid crystals activate the NALP3 inflammasome
10.1038/nature04516 · doi-reference
Association between periodontitis and uric acid levels in blood and oral fluids: a systematic review and meta-analysis
10.1186/s12903-023-02900-8 · doi-reference
Gout can increase the risk of periodontal disease in Taiwan
10.1080/00325481.2020.1757267 · doi-reference
Recent progress and perspectives on the relationship between hyperuricemia and periodontitis
10.3389/fimmu.2022.995582 · doi-reference
Impact of nonsurgical periodontal treatment on arterial stiffness outcomes related to endothelial dysfunction: A systematic review and meta-analysis
10.1002/jper.24-0422 · doi-reference
The prevalence and severity of periodontal disease in Mainland China: data from the fourth national oral health survey (2015–2016)
10.1111/jcpe.13396 · doi-reference
Periodontitis: from microbial immune subversion to systemic inflammation
10.1038/nri3785 · doi-reference
The burden of severe periodontitis in China from 1990 to 2021, with projections to 2050: a comprehensive analysis from the global burden of disease study 2021
10.1016/j.identj.2024.12.013 · doi-reference
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options
10.1186/s12916-017-0890-9 · doi-reference
A systematic review of the cost burden of gout
10.1016/j.jval.2015.09.2371 · doi-reference
A comprehensive analysis of trends in the burden of gout in China and globally from 1990 to 2021
10.1038/s41598-025-86090-z · doi-reference
Prevalence and risk factors of hyperuricemia and gout: a cross-sectional survey from 31 provinces in mainland China
10.2478/jtim-2022-0031 · doi-reference